A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

Heil, Gerhard; Hoelzer, Dieter; Á. Sanz, Miguel; Lechner, Klaus; A. Liu Yin, John; Francesco Sferrazza Papa, Giuseppe; Noens, L.; Szer, Jeff; Ganser, Arnold; O’Brien, Caroline; Matcham, James; Barge, Alan

doi:10.1182/blood.v90.12.4710

Public

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

Published in Blood • Dec 15, 1997

Authors:

Gerhard Heil

Dieter Hoelzer

Miguel Á. Sanz

Abstract

The safety and efficacy of filgrastim as an adjunct to acute myeloid leukemia (AML) induction and consolidation therapy was assessed in this prospective double-blind, randomized, placebo-controlled, multicenter trial. A total of 521 consecutive de novo AML patients aged 16 or more years were randomi...

Subject

Filgrastim

Medicine

Induction chemotherapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!